May 2008
Volume 49, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2008
Comparing the Cellular Mediators of Vitreous Fluid From Vitreoretinal Disorders
Author Affiliations & Notes
  • M. Sugahara
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • T. Yoshimura
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • K.-H. Sonoda
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • Y. Mochizuki
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • H. Enaida
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • Y. Oshima
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • A. Ueno
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • Y. Hata
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • T. Ishibashi
    Ophthalmology, Kyushu Univ. School of Medicine, Fukuoka, Japan
  • Footnotes
    Commercial Relationships  M. Sugahara, None; T. Yoshimura, None; K. Sonoda, None; Y. Mochizuki, None; H. Enaida, None; Y. Oshima, None; A. Ueno, None; Y. Hata, None; T. Ishibashi, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2008, Vol.49, 763. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M. Sugahara, T. Yoshimura, K.-H. Sonoda, Y. Mochizuki, H. Enaida, Y. Oshima, A. Ueno, Y. Hata, T. Ishibashi; Comparing the Cellular Mediators of Vitreous Fluid From Vitreoretinal Disorders. Invest. Ophthalmol. Vis. Sci. 2008;49(13):763. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Vitreoretinal diseases are assumed to be caused by increased concentration of cellular mediators, such as cytokines, chemokines, and growth factors in the vitreous fluid. We have previously shown the comprehensive analysis of vitreous fluid of diabetic patients using microbead-based multiplex ELISA system (Luminex®). On this system, next we aimed to compare the levels of cellular mediators in the vitreous fluid from several vitreoretinal disorders.

Methods: : We studied 426patients; 92 patients with diabetic macular edema (DME), 146 with proliferative diabetic retinopathy (PDR), 28 with branch retinal vein occlusion (BRVO), 13 with central retinal vein occlusion (CRVO), 63 with retinal detachment (RD), and 49 with nonischemic/nonproliferative ocular disease, such as macular hole and epiretinal membrane (control). Vitreous fluid samples were obtained at the time of vitreoretinal surgery, and various cellular mediators were measured simultaneously by microbead-based multiplex ELISA system; (1) proinflammatory cytokines such as GM-CSF, IL-1β, IL-6, IL-8, IL-17 and TNF-α; (2) T cell-related cytokines: IFN-γ, IL-2, IL-4, IL-5, and IL-10; (3) growth factors: EGF, VEGF, basic FGF, and G-CSF; and (4) chemokines: eotaxin, IP-10, MCP-1, MIP-1α, MIP-1β, and RANTES.

Results: : IL-6, IL-8, MCP-1 and VEGF were detectable in vitreous fluid and significantly elevated in patients with described above compared with control patients. The most severe, complicated elevation of these cellular mediators were seen in patients with CRVO. Compared with DME, IL-6, IL-8, and VEGF are significantly elevated in PDR and CRVO patients. In RD patients, IL-6 and MCP-1 was significantly elevated as well as CRVO. In contrast, T cell-related cytokines and chemokines were not detectable in any samples.

Conclusions: : We compared the levels and patterns of vitreous cellular mediators from several vitreoretinal diseases. Of all 21 cellular mediators, IL-6, IL-8, MCP-1, and VEGF may be the key factors to determine the pathogenesis of individual disorders.

Keywords: inflammation • cytokines/chemokines • vitreous 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×